ORGANOGENESIS HOLDINGS INC. (ORGO) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 128.67M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 128.67M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 128.67M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 128.67M | (m) | (m) |
| 2026-03-31 | 128.67M | (m) | (m) |
| 2025-09-30 | 126.91M | (m) | (m) |
| 2025-06-30 | 126.86M | (m) | (m) |
| 2025-03-31 | 126.85M | (m) | (m) |
| 2024-09-30 | 132.58M | (m) | (m) |
| 2024-06-30 | 132.58M | (m) | (m) |
| 2024-03-31 | 132.57M | (m) | (m) |
| 2023-12-31 | 131.96M | (m) | (m) |
| 2023-09-30 | 132.04M | (m) | (m) |
| 2023-06-30 | 131.31M | (m) | (m) |
| 2023-03-31 | 131.26M | (m) | (m) |
| 2022-12-31 | 131.18M | (m) | (m) |
| 2022-09-30 | 130.92M | (m) | (m) |
| 2022-06-30 | 130.89M | (m) | (m) |
| 2022-03-31 | 129.13M | (m) | (m) |
| 2021-12-31 | 128.77M | (m) | (m) |
| 2021-09-30 | 128.64M | (m) | (m) |
| 2021-06-30 | 128.58M | (m) | (m) |
| 2021-03-31 | 128.22M | (m) | (m) |
| 2020-12-31 | 127.99M | (m) | (m) |
| 2020-09-30 | 107.79M | (m) | (m) |
| 2020-06-30 | 105.42M | (m) | (m) |
| 2020-03-31 | 106.11M | (m) | (m) |
| 2019-12-31 | 105.36M | (m) | (m) |
| 2019-09-30 | 94.74M | (m) | (m) |
| 2019-06-30 | 91.34M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |